Home  |  Contact

UniProtKB/Swiss-Prot P35575: Variant p.Thr108Ile

Glucose-6-phosphatase catalytic subunit 1
Gene: G6PC1
Variant information

Variant position:  108
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Threonine (T) to Isoleucine (I) at position 108 (T108I, p.Thr108Ile).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (T) to medium size and hydrophobic (I)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In GSD1A.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  108
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  357
The length of the canonical sequence.

Location on the sequence:   VLDTDYYSNTSVPLIKQFPV  T CETGPGSPSGHAMGTAGVYY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VLDTDYYSNTSVPLIKQFPVTCETGPGSPSGHAMGTAGVYY

Mouse                         VLDTDYYSNSSVPIIKQFPVTCETGPGSPSGHAMGAAGVYY

Rat                           VLDTDYYSNSSVPLIKQFPVTCETGPGSPSGHAMGTAGVYY

Bovine                        VLDTDYYSNTSAPLIKQFPVTCETGPGSPSGHAMGTAGVYY

Cat                           VMDTDYYSNASVPLIKQFPVTCETGPGSPSGHAMGTAGVYY

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 357 Glucose-6-phosphatase catalytic subunit 1
Topological domain 82 – 117 Lumenal
Active site 119 – 119 Proton donor
Glycosylation 96 – 96 N-linked (GlcNAc...) asparagine
Mutagenesis 119 – 119 H -> A. Loss of glucose-6-phosphatase activity.


Literature citations

Identification of three novel mutations (Q54P, W70X and T108I) in the glucose-6-phosphatase gene of patients with glycogen storage disease type Ia.
Trioche P.; Francoual J.; Chalas J.; Capel L.; Bernard O.; Labrune P.;
Hum. Mutat. 14:91-91(1999)
Cited for: VARIANTS GSD1A PRO-54 AND ILE-108;

Genetic heterogeneity of glycogen storage disease type Ia in France: a study of 48 patients.
Trioche P.; Francoual J.; Chalas J.; Capel L.; Lindenbaum A.; Odievre M.; Labrune P.;
Hum. Mutat. 16:444-444(2000)
Cited for: VARIANTS GSD1A ARG-5; VAL-38; PRO-54; CYS-83; ILE-108; LYS-110; ILE-111; GLU-184; ARG-188; THR-241; ARG-270; VAL-270; LEU-322; PHE-327 DEL AND PHE-338;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.